STRUCTURAL DYNAMICS

New science for European ps time-resolved Laue X-ray diffraction

 Coordinatore IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙000˙000 €
 EC contributo 1˙000˙000 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2007-StG
 Funding Scheme ERC-SG
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-12-01   -   2012-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Dr.
Nome: Jasper J.
Cognome: Van Thor
Email: send email
Telefono: 020-75945071

UK (LONDON) hostInstitution 0.00
2    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Ms.
Nome: Brooke
Cognome: Alasya
Email: send email
Telefono: +44 207 594 1181
Fax: +44 207 594 1418

UK (LONDON) hostInstitution 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

beamline    laue    optical    dynamics    recent    time    spectroscopic    biological    id    ray    proteins    reactivity    years    probe    structural    protein    reaction    light    experiments    esrf    pump       sensitive    area    molecular   

 Obiettivo del progetto (Objective)

'I pursue the study of molecular reaction dynamics of biomolecules mostly in the non-coherent time-regime using spectroscopic and X-ray structural techniques. In recent years, breakthroughs in the field of pump-probe X-ray crystallographic structure determination of reaction intermediates of light-sensitive proteins have generated much excitement. These experiments provide insight of key Biological importance and marry structural observations with spectroscopic studies to understand molecular reactivity. My work focuses on the light-sensitive proteins in particular to provide structural dynamics understanding of photoreactions and Biological signalling. The European Synchrotron Radiation Facility is investing in this area, providing and integrating technology that has been developed for pump-probe experiments using the pink-Laue technique in new designs for an upgraded and advanced beamline at ESRF. Historically, research groups in the US have dominated this field and the recent commissioning of the Biocars pump-probe beamline 14-ID-B at APS which has capabilities similar to ID09B at ESRF shows that international competition is strong. While technical capabilities of these two sources have rapidly developed, there has been an obvious lag in applications for the methodology. So far, photolysis of heme proteins (myoglobin-CO and recently FixL) and a photoreceptor molecule called Photoactive Yellow Protein (PYP) have been targets for pump-probe experiments. Clearly it is of strong strategic importance for European science to compete in this area. I have invested four years to develop the Green Fluorescent Protein as a new application, focussing on both time-resolved Laue diffraction as well as ultrafast vibrational and visible spectroscopy to characterise structural dynamics and to establish excited state absorption properties and reactivity for optical pulse profile optimisation for providing sufficient optical penetration. Here, I request European support for establi'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

ZFISHSLEEP (2012)

Resolving the Neuropharmacology and Genetics of Zebrafish Sleep

Read More  

MANITOP (2008)

Massive Neutrinos: Investigating their Theoretical Origin and Phenomenology

Read More  

ARCAS (2012)

ARCAS: Analysis of the Route to Commercialisation of MVA based influenza vaccines

Read More